Involvement of 5-lipoxygenase in survival of Epstein–Barr virus (EBV)-converted B lymphoma cells

Gregory, 1991, Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis, Nature, 349, 612, 10.1038/349612a0 Ruf, 1999, Epstein–Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma, Mol. Cell. Biol., 19, 1651, 10.1128/MCB.19.3.1651 Komano, 1999, Oncogenic role of Epstein–Barr virus-encoded RNAs in Burkitt’s lymphoma cell line Akata, J. Virol., 73, 9827, 10.1128/JVI.73.12.9827-9831.1999 Dawson, 2003, Epstein–Barr virus latent membrane protein 1(LMP1) activates the phosphatidylinsitol 3-kinase/Akt pathway to promote cell survival and induce filament remodelling, J. Biol. Chem., 278, 3694, 10.1074/jbc.M209840200 Portis, 2004, Epstein–Barr virus (EBV) mediates B-lymphocyte survival through constitutive activation of Ras/PI3K/Akt pathway, Oncogene, 23, 8519, 10.1038/sj.onc.1207905 Thomas, 2004, Hodgkin’s lymphoma: molecular biology of Hodgkin and Redd-Sternberg cells, Lancet (Oncology), 5, 11, 10.1016/S1470-2045(03)01319-6 Gualandi, 2001, Enhancement of genetic instability in human B cells by Epstein–Barr virus (EBV) latent infection, Mutagenesis, 16, 10.1093/mutage/16.3.203 Toyokuni, 1995, Persistent oxidative stress in cancer, FEBS Lett., 358, 1, 10.1016/0014-5793(94)01368-B Bowie, 2000, Oxidative stress and nuclear factor-kB activation, Biochem. Pharmacol., 59, 13, 10.1016/S0006-2952(99)00296-8 Anderson, 1994, Separation of oxidant-initiated and redox-regulated steps in the NF-kB signal transdution pathway, Proc. Natl. Acad. Sci. USA, 91, 11527, 10.1073/pnas.91.24.11527 Schwarz, 1998, Oxidative stress during viral infection: a review, Free Radic. Biol. Med., 21, 641, 10.1016/0891-5849(96)00131-1 Wang, 1999, The role of superoxide radical in TNF-alpha induced NF-kappaB activation, Ann. Clin. Sci., 29, 192 Bonizzi, 1999, Reactive oxigen intermediate-dependent NFkB activation by interleukin-1β requires 5-lipoxygenase or NADPH oxidase activity, Mol. Cell. Biol., 19, 1950, 10.1128/MCB.19.3.1950 Gunasekar, 1998, Cyanide-induced generation of oxidative species: involvement of nitric oxide synthase and cyclooxygenase-2, J. Pharmacol. Exp. Ther., 285, 236 Tang, 1993, Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis, Proc. Natl. Acad. Sci USA, 93, 5241, 10.1073/pnas.93.11.5241 Maccarone, 1999, Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity, Eur. J. Biochem., 265, 27, 10.1046/j.1432-1327.1999.00630.x Romano, 2001, 5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor, FASEB J., 15, 2326, 10.1096/fj.01-0150com Ford-Hutchinson, 1994, 5-Lipoxygenase, Annu. Rev. Biochem., 63, 383, 10.1146/annurev.bi.63.070194.002123 Tang, 1997, Apoptosis of W256 carcinosarcoma cells of the monocitoid origin induced by ndga involves lipid peroxidation and depletion of gsh: role of 12-lipoxygenase in regulating tumor cell survival, J. Cell Physiol., 172, 155, 10.1002/(SICI)1097-4652(199708)172:2<155::AID-JCP3>3.0.CO;2-N Ghosh, 1998, Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells, Proc. Natl. Acad. Sci. USA, 95, 13182, 10.1073/pnas.95.22.13182 Werz, 2000, Reactive oxygen species released from granulocytes stimulate 5-lipoxygenase activity in a B-lymphocytic cell line, Eur. J. Biochem, 267, 1263, 10.1046/j.1432-1327.2000.01000.x Farrel, 1991, p53 is frequently mutated in Burkitt’s lymphoma cell lines, EMBO J., 10, 2879, 10.1002/j.1460-2075.1991.tb07837.x Hurley, 1991, When Epstein–Barr virus persistently infects B-cell lines, it frequently integrates, J. Virol., 65, 1245, 10.1128/JVI.65.3.1245-1254.1991 Gargano, 1992, Different localization of EBV genome genome in two subclones of the Burkitt lymphoma line Namalwa, Genes, Chromosomes Cancer, 4, 205, 10.1002/gcc.2870040303 Ghibelli, 1995, Protease inhibitors block apoptosis at intermediate stages: a compared analysis of DNA fragmentation and apoptotic nuclear morphology, FEBS Lett., 377, 9, 10.1016/0014-5793(95)01284-2 Kayanoki, 1994, Suppression of antioxidative enzymes by TGF-b in hepatocytes, J. Biol. Chem., 269, 15488, 10.1016/S0021-9258(17)40705-8 Jakobson, 1991, Human B-lymphocytes possess 5-lipoxygenase activity and convert arachidonic acid to leukotriene B4, Biochem. Biophys. Res. Commun., 178, 302, 10.1016/0006-291X(91)91814-S Feuillard, 2000, Inducible loss of NFkB activity is associated with apoptosis and Bcl2 down-regulation in Epstein–Barr virus-transformed B lymphocytes, Blood, 95, 2068, 10.1182/blood.V95.6.2068.2068 Petrich, 1996, The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)eicosatetranoic acid: structure–activity relationship and mechanism of action, Biochem. J., 314, 911, 10.1042/bj3140911 Shureiqi, 2001, Lipoxygenase modulation to reverse carcinogenesis, Cancer Res., 61, 6307 Ding, 2003, Multiple signal pathways are involved in mitogenic effect of 5-(S)-HETE in human pancreatic cancer, Oncology, 65, 285, 10.1159/000074640